Literature DB >> 27133016

The Prevalence of Hydroxychloroquine Retinopathy and Toxic Dosing, and the Role of the Ophthalmologist in Reducing Both.

David J Browning1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27133016     DOI: 10.1016/j.ajo.2016.03.044

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  6 in total

1.  Solving the Hydroxychloroquine Dosing Dilemma With a Smartphone App.

Authors:  Elliot M Perlman; Paul B Greenberg; David Browning; Robert P Friday; Joan W Miller
Journal:  JAMA Ophthalmol       Date:  2018-02-01       Impact factor: 7.389

2.  Hydroxychloroquine dosing in immune-mediated diseases: implications for patient safety.

Authors:  Milena A Gianfrancesco; Gabriela Schmajuk; Sarah Haserodt; Laura Trupin; Zara Izadi; Kashif Jafri; Stephen Shiboski; Marina Sirota; Jinoos Yazdany
Journal:  Rheumatol Int       Date:  2017-07-26       Impact factor: 2.631

3.  Somatotype, the risk of hydroxychloroquine retinopathy, and safe daily dosing guidelines.

Authors:  David J Browning; Chong Lee
Journal:  Clin Ophthalmol       Date:  2018-05-03

4.  Drug-related problems in patients with rheumatoid arthritis.

Authors:  Shu Ning Ma; Hasniza Zaman Huri; Fariz Yahya
Journal:  Ther Clin Risk Manag       Date:  2019-03-21       Impact factor: 2.423

5.  Discontinuation of hydroxychloroquine in older patients with systemic lupus erythematosus: a multicenter retrospective study.

Authors:  Ruth Fernandez-Ruiz; Nicole Bornkamp; Mimi Y Kim; Anca Askanase; Anna Zezon; Chung-E Tseng; H Michael Belmont; Amit Saxena; Jane E Salmon; Michael Lockshin; Jill P Buyon; Peter M Izmirly
Journal:  Arthritis Res Ther       Date:  2020-08-17       Impact factor: 5.156

6.  Quantitative Fundus Autofluorescence in Systemic Chloroquine/Hydroxychloroquine Therapy.

Authors:  Clara Reichel; Andreas Berlin; Victoria Radun; Ioana-Sandra Tarau; Jost Hillenkamp; Nikolai Kleefeldt; Kenneth R Sloan; Thomas Ach
Journal:  Transl Vis Sci Technol       Date:  2020-08-28       Impact factor: 3.283

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.